Corium
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Corium sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Corium: 8 sponsored US clinical trials, none currently recruiting.
Corium sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 2 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimers Disease, with 1 trials.
Upper-quartile sponsor footprint
Corium sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
NCT05721235
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
NCT05685732
Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
NCT04617782
A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)
NCT03438604
A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations
NCT03432195
A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
NCT03397862
A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
NCT03259958
A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
NCT02968719
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 4 | 2 |
Therapeutic Areas
How the Corium early-phase archive is shaped
8 indexed studies, none listed as recruiting (0% open); 8 completed (100%).
Phase mix: 2 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Alzheimers Disease (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Corium: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Corium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Corium page
8 registered trials is a research-attention snapshot, not an endorsement of Corium or any single study.
- None of Corium's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Alzheimers Disease is the condition Corium studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimers Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Corium pipeline card: 8 registered trials from official public datasets.Report a data error.